Drugs / High-dose ascorbate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07177079 | Mar 2026 → Dec 2028 expected | acute myeloid leukemia | Kittika Poonsombudlert | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High-dose ascorbate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07177079 ↗ |
| Known as | Vitamin C | “Vitamin C” NCT07177079 ↗ |
| Route | Intravenous | “Administering vitamin C intravenously” NCT07177079 ↗ |